Sunday, June 22, 2025

Tag: biologics

Browse our exclusive articles!

Biocon Biologics launches Stelara biosimilar YESINTEK in US for autoimmune diseases

Market admin admin -
Biotechnology firm Biocon Ltd on Monday (February 24) said its unit Biocon Biologics announced the US market availability of YESINTEK (ustekinumab-kfce), a biosimilar to...

Biocon Biologics sees insulin demand growing across markets, says CEO Tambe

New admin admin -
Tambe said the company, a subsidiary of the Bengaluru-based Biocon Ltd, has five products in the pipeline for launch in the US, including Bevacizumab...

Biocon buys back an investor stake in biologics unit, posts Rs 25 crore net profit in Q3FY25

New admin admin -
Biocon's board has approved the acquisition of 1.5% equity in Biocon Biologics for Rs 550 crore, increasing its stake to 90.2%. The deal is...

Popular

Iran Israel war: PM Modi speaks with Iranian President Pezeshkian, calls for de-escalation

Global 0
Prime Minister Narendra Modi on Sunday (June 22) conveyed...

Israel says the remains of 3 hostages have been recovered from Gaza

Global 0
The Israeli military says it has recovered the remains...

Surging travel in Europe spikes concerns over tourism’s drawbacks

Latest 0
Suitcases rattle against cobblestones. Selfie-snappers jostle for the same...

US strike on Iranian nuclear sites sparks fears of wider conflict; UN calls for restraint

Global 0
Israel-Iran Conflict: The US strike on Iran has intensified...

Subscribe

spot_imgspot_img
© 2025 JMD Associates. All Rights Reserved. Partnered with Master Trust for Comprehensive Investment Solutions.